Navigation Links
Malaria's newest pathway into human cells identified

Development of an effective vaccine for malaria is a step closer following identification of a key pathway used by the malaria parasite to infect human cells. The discovery, by researchers at The Walter and Eliza Hall Institute in Melbourne, Australia, provides a new vaccine target through which infection with the deadly disease could be prevented.

Each year more than 400 million people contract malaria, and more than one million, mostly children, die from the disease. The most lethal form of malaria is caused by the parasite Plasmodium falciparum. Part of the parasite's success lies in its ability to deploy multiple ways to invade red blood cells, a process essential for the survival of the parasite within the human host.

Professor Alan Cowman, head of the institute's Infection and Immunity division, led the research with Dr Wai-Hong Tham, Dr Danny Wilson, Mr Sash Lopaticki, Mr Jason Corbin, Dr Dave Richard, Dr James Beeson from the institute and collaborators at the University of Edinburgh.

For decades, it has been known that malaria parasites use proteins called glycophorins as a means of entering red blood cells. This new research reveals an alternative pathway used by the parasite to enter red blood cells. The pathway does not involve glycophorins, instead requiring the binding of a parasite molecule named PfRh4 to Complement Receptor 1 (CR1), a common protein found on the surface of red blood cells.

"The parasite is like a master burglar it will try a variety of different methods to get into the house, not just the front door," Professor Cowman said. "Although the human body has evolved a variety of methods to keep the parasite out, it keeps finding new ways to get in."

Professor Cowman said the PfRh family of surface proteins is involved in the recognition of red blood cell receptors, which allows the parasite to attach to the red blood cell surface and gain entry.

"We think that the parasite uses this protein to correctly identify the red blood cell and say 'Yes, this is the one we want to invade', it's like a quality assurance process," Professor Cowman said.

"The PfRh4-CR1 pathway is one of the most important of the pathways we've identified for entry of malaria parasites into cells," Professor Cowman said. "We are now at the stage where we have identified the best combination of proteins for a vaccine, and are ready to start clinical development.

"When both glycophorin and CR1 pathways are blocked, there is a 90 per cent decrease in infection of the cells with the parasite. These results suggest that if a vaccine were to stimulate the immune system to recognise and generate antibodies to the prevalent invasion pathways, there is a good chance it would lead to a significant decrease in malaria infection."


Contact: Penny Fannin
Walter and Eliza Hall Institute

Related biology news :

1. Electricity collected from the air could become the newest alternative energy source
2. New 2009 Impact Factors soar for newest Cell Press journals
3. UT Southwestern patient first in North Texas to receive newest-generation heart failure device
4. Scripps scientists develop test providing new pathway for identifying obesity, diabetes drugs
5. Discovery of key pathway interaction may lead to therapies that aid brain growth and repair
6. New pathway identified in Parkinsons through brain imaging
7. Calcium connections: Basic pathway for maintaining cells fuel stores
8. Mapping out pathways to better soybeans
9. NIH-supported study finds novel pathway may open doors for new blood pressure treatments
10. UMMS researchers uncover novel genetic pathway responsible for triggering vascular growth
11. Second plant pathway could improve nutrition, biofuel production
Post Your Comments:
Related Image:
Malaria's newest pathway into human cells identified
(Date:5/12/2016)... 12, 2016 , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:4/26/2016)... and LONDON , April ... part of EdgeVerve Systems, a product subsidiary of ... today announced a partnership to integrate the Onegini ...      (Logo: ) ... their customers enhanced security to access and transact ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
(Date:6/23/2016)... 23, 2016 adds ... to its pharmaceuticals section with historic and forecast ... much more. Complete report on the ... profiling 15 companies and supported with 261 tables ... . The Global Cell Culture ...
Breaking Biology Technology: